Scotiabank Increases Omega Healthcare Investors (NYSE:OHI) Price Target to $33.00

Omega Healthcare Investors (NYSE:OHI) had its target price hoisted by investment analysts at Scotiabank from $32.00 to $33.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s price target would suggest a potential downside of 3.06% from the company’s current price.

A number of other analysts also recently commented on OHI. Citigroup raised Omega Healthcare Investors from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $32.00 to $35.00 in a research note on Friday, March 22nd. JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a research note on Monday, May 6th. Truist Financial boosted their price objective on Omega Healthcare Investors from $32.00 to $33.00 and gave the stock a “hold” rating in a research note on Wednesday, June 26th. Finally, Wells Fargo & Company raised Omega Healthcare Investors to a “strong-buy” rating in a research note on Friday, June 14th. Nine analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Hold” and an average price target of $33.65.

Omega Healthcare Investors Stock Up 1.5 %

Shares of Omega Healthcare Investors stock opened at $34.04 on Tuesday. Omega Healthcare Investors has a 1-year low of $27.53 and a 1-year high of $34.77. The company has a debt-to-equity ratio of 1.36, a current ratio of 6.68 and a quick ratio of 6.68. The business’s fifty day moving average price is $32.20 and its two-hundred day moving average price is $31.13. The company has a market capitalization of $8.41 billion, a P/E ratio of 30.67, a PEG ratio of 1.24 and a beta of 0.97.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Omega Healthcare Investors by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock worth $1,120,478,000 after purchasing an additional 165,105 shares during the last quarter. Centersquare Investment Management LLC boosted its stake in shares of Omega Healthcare Investors by 36.6% during the 4th quarter. Centersquare Investment Management LLC now owns 3,585,255 shares of the real estate investment trust’s stock worth $109,924,000 after acquiring an additional 960,997 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Omega Healthcare Investors by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,501,495 shares of the real estate investment trust’s stock worth $107,358,000 after acquiring an additional 40,999 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Omega Healthcare Investors by 4.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,948,554 shares of the real estate investment trust’s stock worth $90,403,000 after acquiring an additional 124,483 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Omega Healthcare Investors during the 4th quarter worth about $61,698,000. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.